Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared with hospital administration: results of a prospective single-center study
Lassalle, A., Thomaré, P., Fronteau, C., Mahé, B., Jubé, C., Blin, N., Voldoire, M., Dubruille, V., Tessoulin, B., Touzeau, C., Chauvin, C., Loirat, M., Lok, A., Bourcier, J., Lestang, E., Mocquet, R., Barbarot, V., Moreau, P.
Published in Annals of oncology (01.02.2016)
Published in Annals of oncology (01.02.2016)
Get full text
Journal Article